NOVO NORDISK A/S

NOVO B
Delayed Quote. Delayed  - 10/20 10:59:49 am
666.7DKK -0.49%

Turn to zoom
Prev.670.0000
Open668.2000
High673.3000
Low661.5000
Volume1 910 479
Latest news
17h ago
2d ago
2d ago
2d ago
Chart NOVO NORDISK A/S
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance670681681
Spread/Res.-0,49%-2,0%-2,0%
Spread/Supp.5,1%21%30%
Support634553511
Financials
Sales 2021 138 B 21 550 M 21 550 M
Net income 2021 46 476 M 7 283 M 7 283 M
Net cash 2021 6 424 M 1 007 M 1 007 M
P/E ratio 2021 33,0x
Yield 2021 1,49%
Capitalization 1 526 B 239 B 239 B
EV / Sales 2021 11,0x
EV / Sales 2022 10,0x
Nbr of Employees 45 971
Free-Float 69,8%
Company
Novo Nordisk AS specializes in the design, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- products for treating diabetes and obesity (84.3%);
- hemophilia treatment products (8.4%): mainly injections of protein;
- growth hormones...

>> Read more
Sector :
Other Pharmaceuticals
Calendar :
2021-11-03 Earnings Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 27
Last Close Price 666,70 DKK
Average target price 613,52 DKK
Spread / Average Target -7,98%